Arch Biopartners Inc.

OTCPK:ACHF.F Stock Report

Market Cap: US$86.9m

Arch Biopartners Management

Management criteria checks 3/4

Arch Biopartners' CEO is Richard Muruve, appointed in Aug 2009, has a tenure of 15.42 years. total yearly compensation is CA$150.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 14.97% of the company’s shares, worth $13.01M. The average tenure of the management team and the board of directors is 13.3 years and 14.7 years respectively.

Key information

Richard Muruve

Chief executive officer

CA$150.0k

Total compensation

CEO salary percentage100.0%
CEO tenure15.4yrs
CEO ownership15.0%
Management average tenure13.3yrs
Board average tenure14.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Richard Muruve's remuneration changed compared to Arch Biopartners's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CA$3m

Mar 31 2024n/an/a

-CA$2m

Dec 31 2023n/an/a

-CA$2m

Sep 30 2023CA$150kCA$150k

-CA$3m

Jun 30 2023n/an/a

-CA$4m

Mar 31 2023n/an/a

-CA$3m

Dec 31 2022n/an/a

-CA$3m

Sep 30 2022CA$113kCA$113k

-CA$1m

Jun 30 2022n/an/a

-CA$257k

Mar 31 2022n/an/a

-CA$423k

Dec 31 2021n/an/a

CA$308k

Sep 30 2021CA$100kCA$100k

-CA$1m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$7m

Dec 31 2020n/an/a

-CA$6m

Sep 30 2020CA$383kCA$100k

-CA$5m

Jun 30 2020n/an/a

-CA$4m

Mar 31 2020n/an/a

-CA$2m

Dec 31 2019n/an/a

-CA$2m

Sep 30 2019CA$100kCA$100k

-CA$2m

Jun 30 2019n/an/a

-CA$2m

Mar 31 2019n/an/a

-CA$3m

Dec 31 2018n/an/a

-CA$3m

Sep 30 2018CA$100kCA$100k

-CA$3m

Compensation vs Market: Richard's total compensation ($USD103.96K) is below average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Richard's compensation has increased whilst the company is unprofitable.

CEO

Richard Muruve (53 yo)

15.4yrs

Tenure

CA$150,000

Compensation

Mr. Richard Gabriel Muruve is a Co-Founder of Arch Biopartners Inc. and has been its Chief Executive Officer since August 2009 and President since May 12, 2010. Mr. Muruve served as Acting Chief Financial...

Leadership Team

NamePositionTenureCompensationOwnership
Richard Muruve
Co-Founder15.4yrsCA$150.00k14.97%
$ 13.0m
Daniel Muruve
Co-Founder13.3yrsCA$289.00k3.16%
$ 2.7m
Andrew Bishop
CFO & Directorno dataCA$289.00k1.2%
$ 1.0m
Justin MacDonald
Co-Founder & Principal Scientistno datano datano data
Paul Beck
Co-Founder & Principal Scientistno datano datano data
Aaron Benson
Director of Communications1.5yrsno datano data

13.3yrs

Average Tenure

Experienced Management: ACHF.F's management team is seasoned and experienced (13.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Richard Muruve
Co-Founder19.4yrsCA$150.00k14.97%
$ 13.0m
Daniel Muruve
Co-Founderno dataCA$289.00k3.16%
$ 2.7m
Andrew Bishop
CFO & Director14.8yrsCA$289.00k1.2%
$ 1.0m
Claude Allary
Independent Director10.8yrsCA$289.00k0.32%
$ 277.4k
Richard Rossman
Independent Director14.7yrsno data3.3%
$ 2.9m
Robert Hodges
Member of Scientific Advisory Boardno datano datano data
Hindrik Mulder
Member of Scientific Advisory Boardno datano datano data

14.7yrs

Average Tenure

63.5yo

Average Age

Experienced Board: ACHF.F's board of directors are seasoned and experienced ( 14.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 10:52
End of Day Share Price 2025/01/10 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arch Biopartners Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chelsea StellickiA Capital Markets
Rahul SarugaserRaymond James Ltd.